These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8065843)

  • 1. Defective stimulation of adipocyte adenylate cyclase, blunted lipolysis, and obesity in pseudohypoparathyroidism 1a.
    Kaartinen JM; Käär ML; Ohisalo JJ
    Pediatr Res; 1994 May; 35(5):594-7. PubMed ID: 8065843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory dysfunction in humans with deficient guanine nucleotide-binding protein.
    Weinstock RS; Wright HN; Spiegel AM; Levine MA; Moses AM
    Nature; 1986 Aug 14-20; 322(6080):635-6. PubMed ID: 3018580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in adipocyte adenylate cyclase activity in morbidly obese and formerly morbidly obese humans.
    Martin LF; Klim CM; Vannucci SJ; Dixon LB; Landis JR; LaNoue KF
    Surgery; 1990 Aug; 108(2):228-34; discussion 234-5. PubMed ID: 2166354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albright hereditary osteodystrophy with hypothyroidism, normocalcemia, and normal Gs protein activity: a family presenting with congenital osteoma cutis.
    Izraeli S; Metzker A; Horev G; Karmi D; Merlob P; Farfel Z
    Am J Med Genet; 1992 Jul; 43(4):764-7. PubMed ID: 1621772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal free fatty acid response to isoproterenol in pseudohypoparathyroidism.
    Carlson HE; Brickman AS; Burns TW; Langley PE
    J Clin Endocrinol Metab; 1985 Aug; 61(2):382-4. PubMed ID: 2989322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of inhibition of a tumor lipid-mobilizing factor by eicosapentaenoic acid.
    Price SA; Tisdale MJ
    Cancer Res; 1998 Nov; 58(21):4827-31. PubMed ID: 9809986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling defect of thyrotropin receptor and adenylate cyclase in a pseudohypoparathyroid patient.
    Mallet E; Carayon P; Amr S; Brunelle P; Ducastelle T; Basuyau JP; de Menibus CH
    J Clin Endocrinol Metab; 1982 May; 54(5):1028-32. PubMed ID: 6277985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast defect in pseudohypoparathyroidism, type I: reduced activity of receptor-cyclase coupling protein.
    Bourne HR; Kaslow HR; Brickman AS; Farfel Z
    J Clin Endocrinol Metab; 1981 Sep; 53(3):636-40. PubMed ID: 6267099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenoceptor-G protein-adenylate cyclase complex in rat hearts with ischemic heart failure produced by coronary artery ligation.
    Yamamoto J; Ohyanagi M; Morita M; Iwasaki T
    J Mol Cell Cardiol; 1994 May; 26(5):617-26. PubMed ID: 8072016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a beta-2 adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation.
    Jocken JW; Blaak EE; Schiffelers S; Arner P; van Baak MA; Saris WH
    Int J Obes (Lond); 2007 May; 31(5):813-9. PubMed ID: 17130852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudohypoparathyroidism: mutation affecting adenylate cyclase.
    Farfel Z; Bourne HR
    Miner Electrolyte Metab; 1982; 8(3-4):227-36. PubMed ID: 6300633
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of Mg2+ on the in vitro responsiveness of adenylate cyclase from hearts of aging rats.
    Pignatti C; Tantini B; Zanfanti ML; Sacchi P; Clo C
    Cardioscience; 1993 Jun; 4(2):105-9. PubMed ID: 8347790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiuretic hormone and lipolysis.
    Bartsokas K; Polychronopoulou-Trichopolou A; Kouvelas ED; Charissiadou A; Valsamakis S; Kalaitzidou C
    Endokrinologie; 1975 Jan; 64(2):201-4. PubMed ID: 1149694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function.
    Iiri T; Herzmark P; Nakamoto JM; van Dop C; Bourne HR
    Nature; 1994 Sep; 371(6493):164-8. PubMed ID: 8072545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic receptor-mediated inhibition of GDP-activated adenylyl cyclase suggests a direct interaction of inhibitory guanine nucleotide-binding proteins and adenylyl cyclase.
    Niroomand F; Bangert M; Philipps C; Rauch B
    Mol Pharmacol; 1993 Jan; 43(1):90-5. PubMed ID: 8380886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Father to son transmission of decreased Ns activity in pseudohypoparathyroidism type Ia.
    Van Dop C; Bourne HR; Neer RM
    J Clin Endocrinol Metab; 1984 Nov; 59(5):825-8. PubMed ID: 6090498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudohypoparathyroidism--another monogenic obesity syndrome.
    Ong KK; Amin R; Dunger DB
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):389-91. PubMed ID: 10718839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation.
    Gando S; Hattori Y; Akaishi Y; Nishihira J; Kanno M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):475-84. PubMed ID: 9223590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the G protein involved in the muscarinic stimulation of adenylyl cyclase of rat olfactory bulb.
    Olianas MC; Onali P
    Mol Pharmacol; 1996 Jan; 49(1):22-9. PubMed ID: 8569708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.